Significance of the Renin-Angiotensin System in Clinical Conditions
Authors:
- Vedran ĐambićVĐVedran Đambić
- Đorđe PojatićĐPĐorđe Pojatić
- Anto StažićASAnto Stažić
- Aleksandar KibelAleksandar Kibel
Open Access
- 19 August 2020
- book chapter
- Published by IntechOpen
Abstract
The renin-angiotensin system, in both its circulating and local tissue roles, is intertwined with multiple other regulatory and signalling mechanisms in various tissues and organ systems. It plays a central role in the normal regulation of arterial blood pressure and in the development of hypertension, which is an immense global public health burden and a crucial modifiable risk factor in the development of cardiovascular diseases. The renin-angiotensin system plays also important roles in a range of other clinical conditions such as heart failure, kidney failure, diabetes mellitus and others. Therapeutic interventions within the renin-angiotensin system include the use of medications such as angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists, which are well established and have been invaluable as clinically effective tools during many years of practical use. Additionally, numerous other therapeutic approaches targeting components of the renin-angiotensin system have been developed or are currently in development. This chapter will discuss details of the roles of this system in the most relevant clinical conditions.Keywords
This publication has 124 references indexed in Scilit:
- The renin‐angiotensin system: a link between obesity, inflammation and insulin resistanceObesity Reviews, 2011
- Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinasesExperimental Physiology, 2011
- Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I FunctionDiabetes, 2010
- Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular DiseasesHypertension, 2010
- Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting GlucoseDiabetes Care, 2009
- Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After StrokeStroke, 2009
- The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin actionDiabetologia, 2009
- (Pro)Renin Receptor Peptide Inhibitor “Handle-Region” Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt RatsHypertension, 2008
- Clinical epidemiology of heart failureHeart, 2007
- Four week administration of an ACE inhibitor and a cardioselective β‐blocker in healthy volunteers: no influence on insulin sensitivityEuropean Journal of Clinical Investigation, 1995